QPCTL inhibitors(Vivoryon Therapeutics)

N/A

Report date: 2025/08/15 14:29:33
NME

Base Information

Drug NameQPCTL inhibitors(Vivoryon Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutaminyl-peptide cyclotransferase-like protein inhibitors
TargetsGlutaminyl-peptide cyclotransferase-like protein
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivoryon Therapeutics NV
China Registration ClassN/A

Develop Information

Active CompaniesVivoryon Therapeutics NV
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A